[Combination treatment of medulloblastomas].
At the time being, the therapy of malignant cerebral tumours cannot yet be considered to be satisfactory. By a combination of various forms of therapy, surgery, radiation therapy, chemotherapy, one tries to achieve optimum results. With respect to the results of the therapy (survival time and survival quality), the medulloblastoma occupies a special position. By employing the combined method, the survival time and also the survival quality can be considerably increased. By the example of one case, the course of the disease in a young medulloblastoma patient is shown whose survival time was six years.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000601:surgery*; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000601:surgery*; D011379:Prognosis; D011879:Radiotherapy Dosage
Zur Kombinationsbehandlung von Medulloblastomen.